MOAT BIOTECHNOLOGY Corp — Form D

MOAT BIOTECHNOLOGY Corp of OKLAHOMA CITY, OK, a company, filed a Form D exempt-offering notice with the SEC on 2023-02-09. The offering totals $20.0M, of which $102K was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (28)

Showing 25 of 28 people.

NameRoleLocation
Todd A FoleyDirectorOklahoma City, OK
Philip A JonesDirectorOklahoma City, OK
Russell A RotherDirectorOklahoma City, OK
Richard A AlvarezExecutive OfficerOklahoma City, OK
Russell A RotherExecutive OfficerOklahoma City, OK
Tetherex Pharmaceuticals A CorporationPromoterOklahoma City, OK
Russell A RotherPromoterOklahoma City, OK
Russell P RotherDirectorSteamboat Springs, CO
Russell P RotherExecutive OfficerSteamboat Springs, CO
Russell P RotherPromoterSteamboat Springs, CO
Tetherex Pharmaceuticals P CorporationPromoterOklahoma City, OK
Michael P Moradi-AraghiDirectorOklahoma City, OK
Scott A RollinsDirectorOklahoma City, OK
Scott A RollinsExecutive OfficerOklahoma City, OK
Scott A RollinsPromoterOklahoma City, OK
Todd P FoleyDirectorAlta, WY
Phillip P JonesDirectorNorman, OK
Todd FoleyDirectorSouth San Francisco, CA
Philip JonesDirectorOklahoma City, OK
Tetherex Pharmaceuticals CorporationPromoterOklahoma City, OK
Richard AlvarezExecutive OfficerPhoenix, AZ
Scott RollinsDirectorOklahoma City, OK
Scott RollinsExecutive OfficerOklahoma City, OK
Scott RollinsPromoterOklahoma City, OK
Russell RotherDirectorOklahoma City, OK

Other filings by this issuer (3)

FiledFormOfferingSold
2025-10-20D$15.6M$26K
2022-10-11D/A$1.5M$1.5M
2022-09-21D$1.0M$1.0M

More